MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Начало・Списък с акции・Arcutis Biotherapeutics Inc

Search

Arcutis Biotherapeutics Inc

Затворен

СекторЗдравеопазване

24.48 -0.16

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

23.77

Максимум

24.49

Ключови измерители
By Trading Economics
Приходи	10M 17M
Продажби	30M 130M
EPS	0.13
Марж на печалбата	13.432
Служители	354
EBITDA	11M 22M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+41.66% upside

Дивиденти
By Dow Jones
Следващи печалби	5.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-231M 3B
Предишно отваряне	24.64
Предишно затваряне	24.48

Настроения в новините

By Acuity

50%

50%

135 / 348 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

12.42 / 14.93 Подкрепа & съпротива

Arcutis Biotherapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.04.2026 г., 23:49 ч. UTC

Значими събития в новините

New Zealand 1Q Inflation Higher Than Expected

20.04.2026 г., 23:10 ч. UTC

Горещи акции

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20.04.2026 г., 22:53 ч. UTC

Значими двигатели на пазара

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20.04.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20.04.2026 г., 23:44 ч. UTC

Пазарно говорене

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20.04.2026 г., 23:39 ч. UTC

Пазарно говорене

Rio Tinto Posts Strong Start to Year -- Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.04.2026 г., 23:30 ч. UTC

Пазарно говорене

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20.04.2026 г., 23:09 ч. UTC

Пазарно говорене

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20.04.2026 г., 22:31 ч. UTC

Придобивния, сливания и поглъщания

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20.04.2026 г., 22:26 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Aims for Acquisition to Be Completed by End-2026

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20.04.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Acquisition Would Be for A$175 Million

20.04.2026 г., 22:24 ч. UTC

Придобивния, сливания и поглъщания

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20.04.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20.04.2026 г., 22:01 ч. UTC

Придобивния, сливания и поглъщания

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20.04.2026 г., 21:38 ч. UTC

Пазарно говорене

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20.04.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20.04.2026 г., 21:24 ч. UTC

Пазарно говорене

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20.04.2026 г., 21:24 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.04.2026 г., 21:13 ч. UTC

Печалби

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20.04.2026 г., 21:10 ч. UTC

Печалби

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20.04.2026 г., 21:09 ч. UTC

Печалби

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20.04.2026 г., 21:08 ч. UTC

Печалби

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20.04.2026 г., 21:07 ч. UTC

Печалби

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20.04.2026 г., 21:05 ч. UTC

Печалби

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20.04.2026 г., 21:05 ч. UTC

Печалби

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Сравнение с други в отрасъла

Ценова промяна

Arcutis Biotherapeutics Inc Прогноза

Ценова цел

By TipRanks

41.66% нагоре

12-месечна прогноза

Среден 34.75 USD 41.66%

Висок 36 USD

Нисък 33 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Arcutis Biotherapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

7

Купи

1

Задържане

0

Продай

Според 8 анализатори, дали борсови рейтинги на Arcutis Biotherapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

12.42 / 14.93Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Настроение

By Acuity

135 / 348 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Други акции от сектора

MDT

Medtronic PLC

85.26

A

Agilent Technologies Inc

120.85

VEEV

Veeva Systems Inc

168.97

HQY

HealthEquity Inc

86.11

NEOG

Neogen Corp

9.63

Live chat